3 free views remaining today

epidermolytic hyperkeratosis 1

Description

Epidermolytic Hyperkeratosis-1 (EHK1): A Rare Autosomal Dominant Disorder

Epidermolytic hyperkeratosis-1 (EHK1) is a rare genetic disorder that affects the skin. It is characterized by an abnormality in the process of epidermal maturation, leading to compact hyperkeratosis, granular, and vacuolar changes in the skin [9].

Key Features:

  • Autosomal Dominant Inheritance: EHK1 is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition [3][8].
  • Present at Birth: The disorder usually presents at birth with erythema and other skin abnormalities [1][3][8].
  • Skin Abnormalities: Affected individuals may have very red skin (erythroderma), severe scaling, and blistering of the skin [4].

Other Forms:

It's worth noting that EHK1 is also known as epidermolytic ichthyosis (EI) or bullous congenital ichthyosiform erythroderma. This condition is a severe form of dry scaly skin that initially presents with redness, blisters, erosions, and peeling in a newborn baby [6][7].

References:

  • [1] Epidermolytic hyperkeratosis-1 (EHK1) is a rare autosomal dominant disorder of cornification. The disorder usually presents at birth with erythema and ...
  • [3] Epidermolytic hyperkeratosis-1 (EHK1) is a rare autosomal dominant disorder of cornification. The disorder usually presents at birth with erythema and ...
  • [8] Epidermolytic hyperkeratosis-1 (EHK1) is a rare autosomal dominant disorder of cornification. The disorder usually presents at birth with erythema and ...
  • [9] Epidermolytic hyperkeratosis is an abnormality of epidermal maturation characterized by compact hyperkeratosis, accompanied by granular and vacuolar ...

Additional Characteristics

  • A rare genetic disorder that affects the skin
  • Characterized by an abnormality in the process of epidermal maturation, leading to compact hyperkeratosis, granular, and vacuolar changes in the skin
  • Inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is enough to cause the condition
  • Usually presents at birth with erythema and other skin abnormalities
  • Affected individuals may have very red skin (erythroderma), severe scaling, and blistering of the skin
  • A severe form of dry scaly skin that initially presents with redness, blisters, erosions, and peeling in a newborn baby

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of epidermolytic hyperkeratosis:

  • Dry eyes [2]
  • Difficulty sweating because thick layers of skin clog the sweat glands [2]
  • Fragile skin that cracks easily and frequently [2]
  • Rough patches of skin from excess keratin [3]
  • Xerosis (dryness) [4]
  • Pruritus (itching) [4]
  • Painful fissuring [4]
  • Redness, blisters, erosions, and peeling in newborn babies [5]
  • Very red skin (erythroderma) and severe skin lesions in affected babies [6]

Note that these symptoms may vary depending on the type of epidermolytic hyperkeratosis.

Additional Symptoms

  • Dry eyes
  • Difficulty sweating because thick layers of skin clog the sweat glands
  • Fragile skin that cracks easily and frequently
  • Rough patches of skin from excess keratin
  • Xerosis (dryness)
  • Painful fissuring
  • Redness, blisters, erosions, and peeling in newborn babies
  • Very red skin (erythroderma) and severe skin lesions in affected babies
  • itching

Diagnostic Tests

Diagnostic Tests for Epidermolytic Hyperkeratosis

Epidermolytic hyperkeratosis, also known as bullous congenital ichthyosiform erythroderma (BCIE), is a rare genetic disorder that affects the skin. Diagnosing this condition can be challenging, but several diagnostic tests can help confirm the diagnosis.

  • Skin Biopsy: A skin biopsy is a crucial diagnostic test for epidermolytic hyperkeratosis. It involves taking a small sample of skin tissue from the affected area and examining it under a microscope. The biopsy can show characteristic features such as hyperkeratosis, epidermolysis, and cytolysis in the stratum corneum [6].
  • Genetic Testing: Genetic testing is another important diagnostic tool for epidermolytic hyperkeratosis. It involves analyzing DNA samples from affected individuals to identify mutations in the keratin genes [5]. This test can confirm the diagnosis and help determine the genetic cause of the condition.
  • Clinical Examination: A thorough clinical examination by a dermatologist or healthcare provider is essential for diagnosing epidermolytic hyperkeratosis. The examination may reveal characteristic skin features such as hyperkeratosis, scaling, and erythema [7].
  • Histological Examination: Histological examination of the skin biopsy can also help confirm the diagnosis. It involves examining the skin tissue under a microscope to look for characteristic features such as hyperkeratosis, epidermolysis, and cytolysis in the stratum corneum [8].

These diagnostic tests can help confirm the diagnosis of epidermolytic hyperkeratosis and rule out other conditions that may present with similar symptoms.

References: [1] Context result 3 [2] Context result 5 [3] Context result 6 [4] Context result 7 [5] Context result 8

Additional Diagnostic Tests

  • Skin Biopsy
  • Histological Examination
  • Genetic Testing
  • Clinical Examination

Treatment

Treatment Options for Epidermolytic Hyperkeratosis

Epidermolytic hyperkeratosis, also known as epidermolytic ichthyosis, is a rare skin disorder that requires careful management to alleviate symptoms. While there is no cure for this condition, various treatment options can help manage its manifestations.

Topical Treatments

  • Topical keratolytics and emollients can be used to soften the skin and reduce hyperkeratotic lesions [9].
  • Mechanical removal of scales can also improve hyperkeratotic lesions, but may worsen blistering in some cases [12].

Oral Medications

Some patients with epidermolytic hyperkeratosis may require oral medications to manage their symptoms. These can include:

  • Antibiotics to prevent skin infections [6].
  • Oral retinoids have been reported to be effective in treating epidermolytic hyperkeratosis, although they can cause significant side effects [13].

Other Treatment Options

In addition to topical and oral treatments, other options may be considered on a case-by-case basis. These can include:

  • Wound care for skin lesions.
  • Antiseptic washes to prevent skin infections.

It's essential to note that treatment regimens typically consist of symptomatic management with the goal of controlling hyperkeratosis [7]. The effectiveness of these treatments may vary depending on individual factors, such as the severity of symptoms and patient response.

Recommended Medications

  • Antibiotics
  • Emollients
  • Topical keratolytics
  • Oral retinoids

đź’Š Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Epidermolytic Hyperkeratosis

Epidermolytic hyperkeratosis, also known as bullous congenital ichthyosiform erythroderma or epidermolytic ichthyosis, is a rare genetic disorder characterized by blistering and scaling of the skin. The differential diagnosis for this condition includes other congenital ichthyoses, vesiculobullous and erosive disorders, and syndromic conditions.

Possible Differential Diagnoses:

  • Ichthyosis vulgaris: A common inherited form of ichthyosis that presents with dry, scaly skin.
  • Incontinentia pigmenti (Bloch–Sulzberger's syndrome): A rare genetic disorder characterized by blistering and scaling of the skin, as well as other systemic features.
  • Lipoid proteinosis: A rare condition characterized by thickening of the skin and mucous membranes due to deposition of lipids and proteins.

Key Features to Consider:

When considering a differential diagnosis for epidermolytic hyperkeratosis, it is essential to note the following key features:

  • Blistering and scaling: The presence of blisters and scales on the skin is a hallmark feature of epidermolytic hyperkeratosis.
  • Genetic inheritance: Epidermolytic hyperkeratosis is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition.
  • Systemic involvement: In some cases, epidermolytic hyperkeratosis may be associated with systemic features such as eye and ear abnormalities.

References:

  • [1] The differential diagnosis for epidermolytic ichthyosis includes other congenital ichthyoses, vesiculobullous and erosive disorders, and syndromic conditions.
  • [2] Ichthyosis vulgaris is a common inherited form of ichthyosis that presents with dry, scaly skin.
  • [3] Incontinentia pigmenti (Bloch–Sulzberger's syndrome) is a rare genetic disorder characterized by blistering and scaling of the skin, as well as other systemic features.

Note: The above information is based on search results 1, 2, 3, and 8.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4179
owl#annotatedSource
t361960
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0081358
core#notation
DOID:0081358
oboInOwl#hasDbXref
ORDO:312
rdf-schema#label
epidermolytic hyperkeratosis 1
IAO_0000115
An epidermolytic hyperkeratosis that is characterized in adulthood by warty flexural hyperkeratosis with fewer erosions and blisters and that usually presents at birth with erythema and blistering and that has_material_basis_in heterozygous mutation in the keratin-1 gene (KRT1) on chromosome 12q13.
rdf-schema#subClassOf
t361972
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.